How Long Does a Cortisone Injection Last? What to Expect Week by Week

Relief after a cortisone shot is real — but it has a timeline. Here's what the research shows, why duration varies, and what to do as the effect begins to fade.

At a Glance

Factor	Typical Range
Onset of relief	1–7 days post-injection
Peak effect	1–2 weeks post-injection
Typical relief window	Several weeks to a few months — 6–12 weeks is a practical average often used clinically
Shortest commonly reported	2–3 weeks
Longest commonly reported	Several months
Common clinical limit	Often 3–4 per joint per year, depending on joint, diagnosis, and clinician guidance

How Long Does a Cortisone Injection Last?

The honest answer is: it depends — and the variation between people is significant. Many people experience relief for several weeks to a few months, with 6–12 weeks a practical average range often used clinically. Individual results vary widely depending on the joint, diagnosis, severity, and injection technique — some people notice the effect fading within 2–3 weeks, while others remain improved for several months.

Several factors determine where in that range your experience falls.

Understanding what drives duration helps you plan around the injection window more effectively — and recognise when pain returning is expected versus when it warrants a conversation with your doctor.

Week-by-Week Timeline After a Cortisone Shot

Days 1–3: The injection site period

Immediately following the injection, some people experience increased soreness at the injection site — sometimes called a cortisone flare. This is a short-term reaction to the crystalline structure of the corticosteroid and typically resolves within 48–72 hours. Ice and rest during this period are generally recommended.

A local anaesthetic is often included in the injection mixture, which may provide immediate but temporary relief for the first few hours before wearing off.

Days 3–7: Initial anti-inflammatory effect

The corticosteroid begins taking effect in the injected area and suppressing the local inflammatory response. Most people notice meaningful pain relief beginning somewhere in this window. Some experience relief within 24–48 hours; others notice improvement closer to day 5–7.

Weeks 1–4: Peak effect

For most people, this is the period of greatest pain reduction. Joint pain and stiffness are at their lowest. Movement is more comfortable. This is the optimal window for beginning or intensifying physiotherapy, as exercises are more accessible when pain is reduced.

Weeks 4–8: Maintained relief

The inflammatory suppression continues at a meaningful level. Most people remain significantly improved. Some begin to notice subtle return of symptoms toward the end of this window — particularly with high-demand joints or more advanced underlying conditions.

Weeks 8–12: Fading effect and return of symptoms

The corticosteroid effect diminishes and the joint returns toward its pre-injection inflammatory environment. For most people with mild to moderate joint conditions, this is when pain and stiffness begin returning. For those with more advanced arthritis or inflammatory conditions, return may occur earlier.

Beyond 12 weeks

Some patients — particularly those with mild joint conditions, younger patients, or those who used the injection window effectively for rehabilitation — report sustained improvement beyond 12 weeks. This is not because the cortisone is still active; it is because the structured rehabilitation or lifestyle changes implemented during the window have begun to modify the joint's longer-term environment.

The injection window is the variable you can act on. What you do during weeks 1–8 significantly influences how the joint behaves at week 12 and beyond.

Why Duration Varies So Much Between People

The underlying condition matters significantly

Cortisone injections tend to last longer in patients with bursitis and tendinitis than in those with established osteoarthritis or rheumatoid arthritis. In bursitis, for example, the inflammatory source is localised and often resolves with adequate suppression. In osteoarthritis, the structural changes in cartilage and the mechanical factors driving inflammation continue regardless of temporary anti-inflammatory intervention.

Joint location influences duration

Weight-bearing joints — knees, hips, ankles, lower back facet joints — are under continuous mechanical load throughout the day. Non-weight-bearing joints, like the shoulder or elbow, experience less sustained compression. Higher load accelerates the return of the inflammatory environment, which is why knee injections often have shorter durations than shoulder injections in the same patient.

Injection technique and placement

Accuracy of placement influences how effectively the cortisone reaches the targeted tissue. Ultrasound-guided injections, which allow real-time visualisation of the needle position, are associated with better placement accuracy and, in some studies, better and longer-lasting outcomes than landmark-guided injections.

Dosage and formulation

Different corticosteroid formulations have different durations of action. Triamcinolone acetonide is among the longer-acting formulations commonly used for joint injections; methylprednisolone has a shorter half-life. Your doctor's choice of formulation is usually based on the specific joint, the nature of the condition, and your medical history.

Activity during the window

High-impact loading of an injected joint — particularly in the first 48–72 hours post-injection — can reduce the duration of effect. Many clinicians recommend reducing strenuous activity for the first 24–48 hours after injection.

Commonly Reported Duration Ranges by Joint

Joint	Commonly Reported Range
Knee	4–8 weeks (range 2–16 weeks)
Shoulder	6–12 weeks
Hip	4–8 weeks
Lumbar facet joints	3–6 weeks typically
Wrist/hand	4–12 weeks
Ankle	4–8 weeks

These are practical clinical ranges, not guarantees. Published research varies by diagnosis, injection type, severity, and technique — the figures above reflect commonly reported patterns rather than a fixed timeline you should expect to match exactly.

Common Side Effects and What They Mean for the Timeline

Blood sugar elevation — corticosteroids can cause a temporary spike in blood glucose levels, typically peaking 24–72 hours post-injection and normalising within a week. People managing diabetes should monitor blood glucose closely in the days following an injection and inform their doctor before the procedure.

Skin and soft tissue changes at the injection site — repeated injections in the same location may cause localised skin thinning or lightening. This is more relevant with frequent injection schedules.

Immune system effects — systemic effects are usually limited with local injections, but larger-dose or repeated injections can still produce temporary whole-body steroid effects in some people.

Cortisone flare — as described, a temporary increase in joint pain within 24–48 hours that resolves without treatment in most cases. This does not indicate a problem with the injection and does not shorten the overall duration of effect.

As the Effect Fades: What Comes Next

Recognising that the cortisone effect is fading — before pain returns to its full pre-injection level — is the most useful moment to plan next steps.

Signs the effect is beginning to wear off:

Morning stiffness beginning to increase
Pain returning after activities that were comfortable during weeks 2–6
The joint requiring more management to feel functional

This typically occurs at weeks 6–10 for most people. At this point, three pathways are worth considering:

1. Continue and build on what the injection window made possible

If physiotherapy, weight management, or targeted joint support have been implemented during the window, the goal is to continue these as the cortisone fades. The rehabilitation and supportive measures begin carrying more of the load as the cortisone reduces.

2. Discuss a repeat injection with your doctor

If the injection provided meaningful improvement, a repeat injection is often appropriate when symptoms return — within the common clinical limit of 3–4 per joint per year. Your doctor will assess whether the underlying condition warrants continued injection management or whether a different approach is more appropriate.

3. Evaluate the longer-term management plan

If multiple injections have provided diminishing returns — each lasting shorter than the last, or relief becoming less complete — this is a signal to discuss alternative approaches. These may include: structured physiotherapy, hyaluronic acid injections (which work through a different mechanism and do not have the same cumulative concerns as corticosteroids), or in advanced cases, surgical consultation.

Supporting the Joint Between Injections

The period between injections is not simply a waiting period. It is an opportunity to support the joint environment in ways that cortisone itself does not.

Physical therapy — strengthening the muscles around the joint reduces mechanical load and is one of the most evidence-based approaches to slowing joint deterioration between injections. (See: The Window Before Knee Replacement Surgery Most People Miss)

Anti-inflammatory diet — systemic dietary omega-3 fatty acids and Mediterranean-pattern eating support a lower inflammatory baseline between injections. (See: Anti-Inflammatory Diet for Joint Pain)

Targeted topical joint support — applying glucosamine and Omega-3 formulations directly over the joint area works through a different route and purpose than the injection, and can become part of a consistent between-injection routine. Anyone using prescription medication or managing a medical condition should confirm with their clinician before adding a new topical product.

URAH Joint Health Omega-3 is designed for this purpose — a transdermal formulation delivering micellar glucosamine and Omega-3 to the application site. For most readers managing the between-injection period, this is the primary daily support option. For active users with heavy post-exercise joint load, URAH Sporting Cream MSM may also be relevant.

When to Contact Your Doctor Before the Scheduled Follow-Up

Pain that is significantly worse than pre-injection levels and has not improved within 72 hours
Fever, excessive warmth, or unusual redness at the injection site (possible infection)
Numbness or tingling that was not present before the injection
Joint pain returning within 2–3 weeks of the injection — shorter than expected

FAQ

How long does it take for a cortisone injection to start working?

Most people notice the beginning of pain relief within 3–7 days of the injection. A local anaesthetic in the injection mixture may provide brief immediate relief, but the corticosteroid effect itself takes a few days to become fully active.

What makes some cortisone injections last longer than others?

Duration is influenced by the underlying condition (bursitis tends to respond longer than advanced arthritis), the joint location (non-weight-bearing joints often last longer), the corticosteroid formulation used, and how actively the injection window is used for rehabilitation.

Is it normal for pain to get worse before it gets better after a cortisone shot?

Yes — a cortisone flare, occurring 24–48 hours post-injection, can temporarily increase joint pain and swelling. This typically resolves within 72 hours and does not affect the overall duration or quality of the injection's effect.

How many cortisone injections can I have per year in the same joint?

Many clinicians limit cortisone injections to 3–4 per joint per year. This reflects concerns about cumulative effects on joint tissue with frequent high-dose corticosteroid exposure. Your doctor will advise on the appropriate schedule for your specific condition.

What should I do as the cortisone effect begins to wear off?

Continue any rehabilitation or joint support routines established during the injection window. Recognise the return of symptoms as a signal to review your overall management plan with your doctor — not necessarily to schedule another injection immediately. Discuss whether the injection window was used effectively and what the next step in longer-term management should be.

References

Zeng C, et al. Intra-articular corticosteroid injections in knee osteoarthritis. Annals of Internal Medicine, 2019.
McAlindon TE, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain. JAMA, 2017.
Sibbitt WL, et al. A randomised controlled trial of the cost-effectiveness of ultrasound-guided versus blind intra-articular injections. Annals of Rheumatic Diseases, 2011.
Onigbinde AT, et al. Transdermal glucosamine for musculoskeletal conditions. Hong Kong Physiotherapy Journal, 2018.